您的位置: 首页 > 农业专利 > 详情页

NOVEL COMPOSITION FOR EXTRACORPOREAL REDUCTION OF BETA-AMYLOIDS AND PROCESS FOR PRODUCING THEREOF
专利权人:
发明人:
申请号:
EP13781268.1
公开号:
EP2841447B1
申请日:
2013.01.30
申请国别(地区):
EP
年份:
2018
代理人:
摘要:
The present invention provides a safe, reliable, and economical process for preparing an improved dialysis fluid formulation effective for extracorporeal treatment, through a blood filtration process, of a Beta-Amyloid associated pathological condition in a subject, said process comprises preparing a composition comprising KLVFF peptide, or a variant thereof, as the capturing and binding agent, and a carrier therefor, and mixing said composition with a dialysate solution. The process utilizes a compact, inexpensive, and simple standard dialysis machine that extracorporeally removes Beta-Amyloids without allowing escape of the Beta-Amyloids back into a subjects body, without having to intricately evaluate the performance and characteristics of a dialysis membrane, and without putting the health condition of the subject at risk.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充